OBJECTIVES: Dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis has frequently been reported in multiple sclerosis (MS). So far, HPA axis function in MS has predominantly been studied under
EBV viral load (copies per μg DNA) was grouped into 3 categories: Low: 100 to 999; moderate: 1000 to 1999, and high: ≥2000/μg DNA. Of the 40 cases with measurable viral load, 3 cases were from non-MS
PPV: positive predictive value, NPV: negative predictive value. Clinical utility of HGF, Eotaxin/CCL11, EGF and MIP-1β/CCL4 as MS biomarkers and clinical utlity of their combination in a model by mult
Cross-sectional, hypothesis-free proteomic study aimed at identifying novel serum biomarkers in MS. A stepwise, or“triangular” biomarker discovery strategy was employed. This approach began with an ex
Cerebrospinal fluid (CSF) is a promising clinical sample for identification of novel biomarkers for various neurological disorders. Considering its direct contact with brain tissue, CSF represents a v